In recent years, the intersection between immunodeficiencies, haematologic conditions, and oncology has become ever more apparent. As we witness increasing complexity in patient diagnoses and treatments, the need for a collaborative, multidisciplinary approach is more critical than ever. This symposium aims to provide a comprehensive platform for exploring how immunodeficiencies can influence hematologic and oncologic conditions and vice versa, and how each specialty offers unique insights that contribute to improving diagnosis, treatment, and management strategies.

This symposium is an important opportunity for fellows, researchers and junior faculty to report and highlight novel basic and clinical information on this interplay of immunodeficiencies and malignant and non-malignant hematological diseases.